Navigation Links
3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
Date:6/16/2008

ST. PAUL, Minn. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- 3M and Gen-Probe Incorporated (Nasdaq: GPRO) announced today that 3M has discontinued the companies' collaboration to develop rapid molecular tests for healthcare-associated infections (HCAIs).

The companies, which are exploring the possibility of a future marketing collaboration in this area, said the collaboration was discontinued due to current technical incompatibilities between Gen-Probe's nucleic acid testing technologies and 3M's proprietary microfluidics instrument platform.

"We intend to evaluate the merits of developing molecular tests for HCAIs to run on our next-generation automated instruments," said Steve Kondor, Gen-Probe's senior vice president of sales and marketing. "This approach, if successful, could help us develop products more rapidly, while further establishing our instrument platforms among current and future low- to mid-volume customers."

3M reaffirmed its commitment to developing and delivering products and solutions for the issues associated with HCAIs. "Our technology platforms are helping hospitals address the important issue of HCAIs," said Chuck Kummeth, vice president and general manager, 3M Medical Division. "We'll continue to offer our customers solutions that detect, prevent and control infections."

Under the terms of the discontinued agreement, Gen-Probe was responsible for assay development, which 3M funded. 3M also agreed to pay milestones to Gen-Probe based on technical and commercial progress. Gen-Probe earned the first of these milestones in the fourth quarter of 2007.

About 3M Health Care

Since inventing Ioban Antimicrobial Incise Surgical Drapes more than 30 years ago, 3M has been a worldwi
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
4. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
5. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
6. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
7. SGX Provides Update on BCR-ABL Collaboration
8. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
9. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
10. Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
11. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...blish duration of efficacy from two hours up to 14... , HOLLYWOOD, Fla., July 1 /PRNewswire-FirstCall...lobal specialty biopharmaceutical company, today a...VYVANSE(R) (lisdexamfetamine dimesylate) CII demon...inistration during a simulated workplace environme...
(Date:7/1/2009)...stCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq...d a European patent for a novel device and methods...ostic and therapeutic applications. The technolog...ed for the production of radiolabeled anti-cancer ...ell. A study published today in the July 2009 iss...
(Date:6/30/2009)... modified chlorophyll from an alga so that it rese...cteria. The team was then able to determine the st... step to converting sunlight into energy using an ...g an article on their research findings in the onl...k starting 29 June. Leiden researcher Swapna Ganap...
(Date:6/30/2009)... 30 Microfluidics, a wholly owned ...ion (OTC Bulletin Board: MFLU), and Particle Scien... help biopharmaceutical companies leverage the mos...tion methods available to develop, analyze and com...). , , Particle Sciences is a leading Contract ...
Breaking Biology Technology:Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 4First step to converting solar energy using 'artificial leaf' 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3
... Governor Jim Doyle today announced that three Wis...ogy development projects from the Department of Co...ogy Venture Fund (TVF) Programs. The three compani...ogies, Inc., and Bell Brook Labs, LLC, Meanwhile ...e Care,s proposed merger. , ,Original air date: Sa...
... Howard Anderson, who teaches courses on early-sta...hnology, founded or co-founded three venture capit...i. Now, hes hanging up his sword, declining to rai...ture money pursuing too few deals. Theres nowhere ...weve raised, Anderson wrote in Technology Review l...
... Madison,Wis. - Esker Software , based in Lyon...Madison, received a U.S. patent for the technology... for enabling content-based document delivery. , ,... data from electronic documents to determine forma...y previously-built rules. It is already in place ...
... A few weeks back, I suggested that the role of ...es and the business. I have this picture in my hea...xotic locales (like the board room) and different ...ituations that could boil over into real conflict ...e, patience and a great deal of flexibility is the...
Other Biology Technology:Is venture capital dead? No, but its beginning a new cycle 2Is venture capital dead? No, but its beginning a new cycle 3IT is the New Foreign Service 2IT is the New Foreign Service 3
(Date:6/30/2009)...We are all familiar with the fact that cognitive f... studies have shown that the specific kind of dail... lives appears to influence the extent of this dec...sitt Berlin are studying how division of labour am...as they age. Surprisingly, they have found that, b...
(Date:6/30/2009)...SHINGTON, DC The misleading "health" halo surroun...ng sweetener reformulations is starting to dim. ,...ds that they will remove high fructose corn syrup ...on in news articles by several experts and respect...n companies, marketing efforts and put forth scien...
(Date:6/30/2009)...geons could be art critics yet, according to a new...n be trained to tell the difference between ,good,...ru Watanabe from Keio University in Japan, pigeons...tings, beauty as defined by humans, as well as the...en published online in Springer,s journal, Animal...
(Date:6/30/2009)...Researchers at the Sahlgrenska Academy, University...n mechanism involved in alcohol addiction involvin...ons in the brain are blocked, alcohol,s effects on... discovery that could lead to new therapies for ad...ts will be published in the renowned American scie...
Breaking Biology News(10 mins):A young brain for an old bee 2Recent news reports of sweetener reformulations raise questions about motivations 2A bird's eye view of art 2Discovery may provide new treatments for alcohol dependence 2NJIT to host major biomedical engineering showcase and career fair 7144 1NJIT to host major biomedical engineering showcase and career fair 7144 2Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 37092 1Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 37092 2Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 37092 3Amicus Therapeutics Announces Change to Board of Directors 10542 1Working With Robots May Help After a Stroke 37090 1Working With Robots May Help After a Stroke 37090 2
...rst time, scientists have documented an organ-spec...in the April 18 edition of the journal Immunity, s...go (UCSD) School of Medicine outline the unique me...ategies against microbial invasion. , "This innate...probably designed to minimize collateral damage to...
...tists at Case Western Reserve University School of...art of the brain that processes our sense of smell... of a group of previously unstudied brain cells de...ounced blon ?es) in the late 1800s. Blanes cells ...aintain memories of smells and also opens a new ap...
...nducted by investigators at Georgia State Universi...roscience (CBN) reports that anatomical and functi...erences in the experience of pain and in the effec...rted in the April 13 issue of the Journal of Compa...differences in the parts of the brain responsible ...
...ave a look at the videos: 1 & 2 , Chemis...technique providing a real-time, molecule-by-molec...heir direct observation of fluorescently tagged mo...-time footage of the birth of individual new prote...s, precision in probing genetic activity. , Using ...
Other Biology News:Researchers reveal lung's unique innate immune system 2Neuroscientists discover new cell type that may help brain maintain memories of smells 2Neuroscientists discover new cell type that may help brain maintain memories of smells 3Brain differences could explain why males and females experience pain relief differently 2Molecule by molecule, new assay shows real-time gene activity 2Molecule by molecule, new assay shows real-time gene activity 3
Acetylcholinesterase (human brain, AChE)
...eets the demands of the routine trace metal analyt...le, robust and simple to use instrumentation. The ...t challenging sample matrices found in the environ...est analytical challenges found in the clinical, f...
C1-inhibitor (C1-INH)
Polio component type I
Biology Products: